NCT05267678

Brief Summary

This prospective cohort study primarily aims to examine the association between blood niacin levels and recurrent miscarriage.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
499

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 21, 2022

Completed
11 days until next milestone

First Posted

Study publicly available on registry

March 4, 2022

Completed
11 months until next milestone

Study Start

First participant enrolled

January 28, 2023

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2024

Completed
Last Updated

June 1, 2023

Status Verified

May 1, 2023

Enrollment Period

1.2 years

First QC Date

February 21, 2022

Last Update Submit

May 30, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Number of participants with miscarriage

    pregnancy outcomes are confirmed by electronic hospital records or self-reported by participants

    6-13(+6) weeks of gestation

  • Gestation week at miscarriage

    pregnancy outcomes are confirmed by electronic hospital records or self-reported by participants

    6-13(+6) weeks of gestation

Study Arms (1)

Pregnant women with history of recurrent miscarriage

Other: No intervention

Interventions

This is an observational study without any intervention

Pregnant women with history of recurrent miscarriage

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Pregnant women with history of recurrent miscarriage

You may qualify if:

  • years old, female
  • Positive blood human chorionic gonadotropin test
  • Naturally pregnant
  • History of recurrent miscarriage (2 or more consecutive spontaneous miscarriage within 28 weeks of gestation)
  • Willing to participate in this study with informed consent

You may not qualify if:

  • Women whose confirmed cause of recurrent miscarriage has nothing to do with nutritional deficiencies, including chromosomal abnormalities, abnormal uterine anatomy, immune system diseases, blood diseases, etc.
  • Women with Hepatitis B, syphilis, HIV/AIDS and other infectious diseases.
  • Women with serious conditions, such as schizophrenia, tumors, heart failure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences

Beijing, Beijing Municipality, 100730, China

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

Maternal blood during pregnancy

MeSH Terms

Conditions

Abortion, Habitual

Condition Hierarchy (Ancestors)

Abortion, SpontaneousPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Hongjun Shi, PhD

    Westlake University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Danyang WANG, MPH

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 21, 2022

First Posted

March 4, 2022

Study Start

January 28, 2023

Primary Completion

April 1, 2024

Study Completion

July 1, 2024

Last Updated

June 1, 2023

Record last verified: 2023-05

Locations